HERTF - Heritage Cannabis Begins Manufacturing For New York Recreational Market with Products Available in the State this August
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that manufacturing of its RAD branded vape and concentrate products has begun and will be available for New York consumers this August.
In April of this year Heritage announced the signing of a manufacturing and distribution agreement with a local New York partner that will produce products using Heritage’s innovative formulations and flavours that the RAD brand is known for. Heritage plans to introduce additional RAD products including live resin, rosin, and infused pre-rolls, and is expanding product offerings with additional Heritage brands.
The New York market is projected to be valued at over $4 billion within five years according to Forbes, and is expected to be second only to the California market in the U.S.
“The New York market has enormous potential, and I am thrilled that the production of RAD branded products has started up in the state,” said David Schwede, CEO of Heritage. “Our U.S. roll-out strategy has a low cash requirement, providing an efficient entry into growing markets and faster path to profitability. Using a methodical approach when entering new markets has worked to Heritage’s benefit, where we can properly and successfully establish a brand and see the growth that follows. The timing of Heritage entering the New York market now, allows us to focus on the launch of our brand and establish Heritage for growth as the market matures.”
About Heritage Cannabis Holdings Corp.
Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“David Schwede”
David Schwede, CEO
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230718665809/en/
For more information contact:
Kelly Castledine
Tel: 647-660-2560